These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2252722)

  • 1. Measurement of back clearance.
    Takesawa S; Saito H; Hidai H; Suzuki M; Sakai K
    ASAIO Trans; 1990; 36(3):M441-3. PubMed ID: 2252722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a reduced inner diameter of hollow fibers in hemodialyzers.
    Ronco C; Brendolan A; Lupi A; Metry G; Levin NW
    Kidney Int; 2000 Aug; 58(2):809-17. PubMed ID: 10916106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysate contamination and back filtration may limit the use of high-flux dialysis membranes.
    Baurmeister U; Travers M; Vienken J; Harding G; Million C; Klein E; Pass T; Wright R
    ASAIO Trans; 1989; 35(3):519-22. PubMed ID: 2597523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass transfer mechanisms in high-performance membrane dialyzers.
    Yamashita AC
    Contrib Nephrol; 2011; 173():95-102. PubMed ID: 21865781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro study of combined convection- diffusion mass transfer in hemodialysers.
    Gupta BB; Jaffrin MY
    Int J Artif Organs; 1984 Sep; 7(5):263-8. PubMed ID: 6500732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
    Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
    ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow continuous ultrafiltration with bound solute dialysis.
    Patzer JF; Safta SA; Miller RH
    ASAIO J; 2006; 52(1):47-58. PubMed ID: 16436890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the permeability of high-flux dialyzer membranes for bacterial pyrogens.
    Schindler R; Christ-Kohlrausch F; Frei U; Shaldon S
    Clin Nephrol; 2003 Jun; 59(6):447-54. PubMed ID: 12834177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of EPO therapy on backfiltration of dialysate in high flux dialysis.
    Robertson BC; Curtin C
    ASAIO Trans; 1990; 36(3):M447-52. PubMed ID: 2252724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution and physical principles of convection-based dialysis treatment].
    David S
    G Ital Nefrol; 2012; 29 Suppl 55():S3-11. PubMed ID: 22723138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ultrafiltration on dialysance. Mathematical theory and experimental verification.
    Hootkins R; Bourgeois B
    ASAIO Trans; 1991; 37(3):M375-7. PubMed ID: 1751195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D; Ji D; Xie H; Xu B; Liu Y; Li L
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dialyzer jacket structure and hollow-fiber dialysis membranes to achieve high dialysis performance.
    Hirano A; Yamamoto K; Matsuda M; Ogawa T; Yakushiji T; Miyasaka T; Sakai K
    Ther Apher Dial; 2011 Feb; 15(1):66-74. PubMed ID: 21272255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
    Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
    Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers.
    Teehan GS; Guo D; Perianayagam MC; Balakrishnan VS; Pereira BJ; Jaber BL
    Blood Purif; 2004; 22(4):329-37. PubMed ID: 15240988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal equilibration test with conventional 'low pH/high glucose degradation product' or with biocompatible 'normal pH/low glucose degradation product' dialysates: does it matter?
    Van Overmeire L; Goffin E; Krzesinski JM; Saint-Remy A; Bovy P; Cornet G; Bovy C
    Nephrol Dial Transplant; 2013 Jul; 28(7):1946-51. PubMed ID: 23223220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of beta-2-microglobulin by diffusion alone is feasible using highly permeable dialysis membranes.
    Naitoh A; Tatsuguchi T; Okada M; Ohmura T; Sakai K
    ASAIO Trans; 1988; 34(3):630-4. PubMed ID: 3058183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of beta 2-microglobulin by a new polyacrylonitrile membrane dialyser: mechanism and physiokinetics.
    Akizawa T; Koshikawa S; Nakazawa R; Yoshida T; Kaneko M; Nitadori Y
    Nephrol Dial Transplant; 1989; 4(5):356-65. PubMed ID: 2505186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ultrafiltration on back-diffusion in hemodialyzer.
    Waniewski J; Lucjanek P; Weryński A
    Artif Organs; 1994 Dec; 18(12):933-6. PubMed ID: 7887831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increases in mass transfer-area coefficients and urea Kt/V with increasing dialysate flow rate are greater for high-flux dialyzers.
    Leypoldt JK; Cheung AK
    Am J Kidney Dis; 2001 Sep; 38(3):575-9. PubMed ID: 11532691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.